Close Menu

Derek Lowe has two items worth reading -- start with this article in The Atlantic, where he offers a good description of the layoff situation in pharma (with a particular focus on the recent Pfizer/Wyeth and Merck/Schering-Plough mergers). "Research scientists in the drug business are going through what may be their worst and most uncertain period ever," he writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.